[go: up one dir, main page]

AU6391000A - Method of preventing the injury or death of retinal cells and treating ocular diseases - Google Patents

Method of preventing the injury or death of retinal cells and treating ocular diseases

Info

Publication number
AU6391000A
AU6391000A AU63910/00A AU6391000A AU6391000A AU 6391000 A AU6391000 A AU 6391000A AU 63910/00 A AU63910/00 A AU 63910/00A AU 6391000 A AU6391000 A AU 6391000A AU 6391000 A AU6391000 A AU 6391000A
Authority
AU
Australia
Prior art keywords
death
injury
preventing
retinal cells
ocular diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63910/00A
Inventor
Avi J. Ashkenazi
Kevin P. Baker
Audrey Goddard
Paul J. Godowski
Austin L. Gurney
Ivar J. Kljavin
Monique La Fleur
Melanie R Mark
Scot A. Marsters
Robert M. Pitti
Colin K. Watanabe
William I. Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1999/020944 external-priority patent/WO2000015792A2/en
Priority claimed from PCT/US1999/021090 external-priority patent/WO2000015796A2/en
Priority claimed from PCT/US1999/028214 external-priority patent/WO2001019987A1/en
Priority claimed from PCT/US1999/028313 external-priority patent/WO2000032221A2/en
Priority claimed from PCT/US1999/028301 external-priority patent/WO2000032776A2/en
Priority claimed from PCT/US2000/000219 external-priority patent/WO2000053753A2/en
Priority claimed from PCT/US2000/000376 external-priority patent/WO2000053755A2/en
Priority claimed from PCT/US2000/003565 external-priority patent/WO2001053486A1/en
Priority claimed from PCT/US2000/004341 external-priority patent/WO2000053756A2/en
Priority claimed from PCT/US2000/004414 external-priority patent/WO2001004311A1/en
Priority claimed from PCT/US2000/005004 external-priority patent/WO2000053757A2/en
Priority claimed from PCT/US2000/005841 external-priority patent/WO2000053758A2/en
Priority claimed from PCT/US2000/006884 external-priority patent/WO2001005972A1/en
Priority claimed from PCT/US2000/008439 external-priority patent/WO2000073454A1/en
Priority claimed from PCT/US2000/013705 external-priority patent/WO2000073445A2/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU6391000A publication Critical patent/AU6391000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/16—Ophthalmology
    • G01N2800/164—Retinal disorders, e.g. retinopathy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU63910/00A 1999-07-28 2000-07-28 Method of preventing the injury or death of retinal cells and treating ocular diseases Abandoned AU6391000A (en)

Applications Claiming Priority (33)

Application Number Priority Date Filing Date Title
US14622299P 1999-07-28 1999-07-28
US60146222 1999-07-28
WOUS99/20944 1999-09-13
PCT/US1999/020944 WO2000015792A2 (en) 1998-09-14 1999-09-13 Promotion or inhibition of angiogenesis and cardiovascularization
PCT/US1999/021090 WO2000015796A2 (en) 1998-09-16 1999-09-15 Secreted and transmembrane polypeptides and nucleic acids encoding the same
WOUS99/21090 1999-09-15
WOUS99/28214 1999-11-29
PCT/US1999/028214 WO2001019987A1 (en) 1999-09-13 1999-11-29 Promotion or inhibition of angiogenesis and cardiovascularization
PCT/US1999/028313 WO2000032221A2 (en) 1998-12-01 1999-11-30 Promotion or inhibition of angiogenesis and cardiovascularization
WOUS99/28313 1999-11-30
WOUS99/28301 1999-12-01
PCT/US1999/028301 WO2000032776A2 (en) 1998-12-01 1999-12-01 Secreted amd transmembrane polypeptides and nucleic acids encoding the same
WOUS00/00219 2000-01-05
PCT/US2000/000219 WO2000053753A2 (en) 1999-03-08 2000-01-05 Promotion or inhibition of angiogenesis and cardiovascularization
WOUS00/00376 2000-01-06
PCT/US2000/000376 WO2000053755A2 (en) 1999-03-08 2000-01-06 Compositions and methods for the treatment of tumor
PCT/US2000/003565 WO2001053486A1 (en) 1999-03-08 2000-02-11 Compositions and methods for the treatment of tumor
WOUS00/03565 2000-02-11
PCT/US2000/004341 WO2000053756A2 (en) 1999-03-08 2000-02-18 Secreted and transmembrane polypeptides and nucleic acids encoding the same
WOUS00/04341 2000-02-18
PCT/US2000/004414 WO2001004311A1 (en) 1999-07-07 2000-02-22 Secreted and transmembrane polypeptides and nucleic acids encoding the same
WOUS00/04414 2000-02-22
PCT/US2000/005004 WO2000053757A2 (en) 1999-03-08 2000-02-24 Promotion or inhibition of angiogenesis and cardiovascularization
WOUS00/05004 2000-02-24
PCT/US2000/005841 WO2000053758A2 (en) 1999-03-08 2000-03-02 Compositions and methods for the treatment of immune related diseases
WOUS00/05841 2000-03-02
PCT/US2000/006884 WO2001005972A1 (en) 1999-07-20 2000-03-15 Compositions and methods for the treatment of immune related diseases
WOUS00/06884 2000-03-15
WOUS00/08439 2000-03-30
PCT/US2000/008439 WO2000073454A1 (en) 1999-06-02 2000-03-30 Secreted and transmembrane polypeptides and nucleic acids encoding the same
WOUS00/13705 2000-05-17
PCT/US2000/013705 WO2000073445A2 (en) 1999-06-02 2000-05-17 Interleukin-1-receptor associated kinase-3 (irak3)
PCT/US2000/020710 WO2001009327A2 (en) 1999-07-28 2000-07-28 Method of preventing the injury or death of retinal cells and treating ocular diseases

Publications (1)

Publication Number Publication Date
AU6391000A true AU6391000A (en) 2001-02-19

Family

ID=22516360

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63910/00A Abandoned AU6391000A (en) 1999-07-28 2000-07-28 Method of preventing the injury or death of retinal cells and treating ocular diseases

Country Status (2)

Country Link
AU (1) AU6391000A (en)
WO (1) WO2001009327A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001049715A2 (en) * 2000-01-06 2001-07-12 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
US7083791B2 (en) 1999-03-25 2006-08-01 Genesis Research & Development Corporation Limited Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
US6242419B1 (en) * 1999-03-25 2001-06-05 Genesis Research & Development Corporation Ltd. Compositions isolated from stromal cells and methods for their use
WO2003002737A1 (en) * 2001-06-27 2003-01-09 Riken Novel human topoisomerase 2α inhibitory protein and utilization thereof
WO2003061519A2 (en) 2002-01-18 2003-07-31 Massachusetts Eye And Ear Infirmary Methods and compositions for preserving the viability of photoreceptor cells
WO2004007749A2 (en) 2002-07-12 2004-01-22 University Of Washington Methods and systems for extended in vitro culture of neuronal cells
US7803375B2 (en) 2005-02-23 2010-09-28 Massachusetts Eye And Ear Infirmary Methods and compositions for treating conditions of the eye
US7592330B2 (en) 2005-08-08 2009-09-22 Massachusetts Eye And Ear Infirmary Methods and compositions for preserving the viability of photoreceptor cells
CN101686665B (en) 2007-04-20 2014-04-23 奥克塞拉有限公司 Styrenyl derivative compounds for treating ophthalmic diseases and disorders
CN101784188B (en) 2007-06-29 2014-02-12 奥克塞拉有限公司 Alkynylphenyl derivatives for use in the treatment of ophthalmic diseases and disorders
WO2009045479A1 (en) 2007-10-05 2009-04-09 Acucela Inc. Alkoxy compounds for disease treatment
RU2387416C1 (en) * 2008-12-18 2010-04-27 Татьяна Андреевна Милевская Method of prevention and treatment of retinopathy in dysmature infants
HK1198514A1 (en) 2012-01-20 2015-05-15 Acucela, Inc. Substituted heterocyclic compounds for disease treatment
EA201591535A1 (en) 2013-03-12 2016-04-29 Акусела Инк. SUBSTITUTED DERIVATIVES OF 3-PHENYL-PROPYLAMINE FOR THE TREATMENT OF OPHTHALMOLOGICAL DISEASES AND DISORDERS
RU2532497C1 (en) * 2013-09-18 2014-11-10 Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Министерства здравоохранения Российской Федерации Method for prediction of regression of stage ii and iii retinopathy of prematurity following laser coagulation of retina
RU2547801C1 (en) * 2013-11-20 2015-04-10 Федеральное государственное бюджетное учреждение "Московский научно-исследовательский институт глазных болезней имени Гельмгольца" Министерства здравоохранения Российской Федерации Method of treating terminal degree of scarry phase of retinopathy in premature babies
RU2596721C1 (en) * 2015-09-18 2016-09-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ГБОУ ВПО РНИМУ им. Н.И. Пирогова Минздрава России) Method of preventing and treating retinopathy of prematurity
RU2605495C1 (en) * 2015-09-18 2016-12-20 Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет имени Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) Method of preventing and treating retinopathy in premature newborns with evident fibrin formation and hemorrhages in retina and vitreous body
KR102250775B1 (en) * 2019-10-18 2021-05-11 주식회사 에스알파테라퓨틱스 Digital apparatus and application for treating myopia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6310040B1 (en) * 1991-11-08 2001-10-30 Cephalon, Inc. Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs
WO1994001124A1 (en) * 1992-07-08 1994-01-20 Celtrix Pharmaceuticals, Inc. METHOD OF TREATING OPHTHALMIC DISORDERS USING TGF-$g(b)
WO2000053753A2 (en) * 1999-03-08 2000-09-14 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization
ES2316153T3 (en) * 1996-08-16 2009-04-01 Human Genome Sciences, Inc. HUMAN ALFA ENDOQUINA.
JP4485049B2 (en) * 1997-11-18 2010-06-16 ジェネンテック， インコーポレイテッド Tumor necrosis factor homologue called DNA19355 polypeptide
IL137409A0 (en) * 1998-02-09 2001-07-24 Genentech Inc Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same

Also Published As

Publication number Publication date
WO2001009327A3 (en) 2001-08-02
WO2001009327A2 (en) 2001-02-08

Similar Documents

Publication Publication Date Title
AU6391000A (en) Method of preventing the injury or death of retinal cells and treating ocular diseases
AU4582797A (en) Methods for treatment of retinal diseases
MXPA01009544A (en) Method for treating and/or preventing retinal diseases with sustained release corticosteroids.
AU2002233643A1 (en) Methods of treating diseases in association with decrease in the expression of AOP-1 gene or AOP-1 and remedies for the diseases
EP0686203A4 (en) Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death
AU7186501A (en) Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
AU2072201A (en) Agents and methods for the treatment of proliferative diseases
AU7748000A (en) Method and composition for the treatment of dermatologic diseases
AU6566094A (en) Heterocyclic derivatives in the treatment of ischaemia and related diseases
AU2307999A (en) Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
AU2039800A (en) 5-membered heterocycles for the treatment of human diseases involving modulatorsof selectins
AU2206699A (en) Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
AU2002307430A1 (en) Method and system for photodisruption of tissue of the eye
IL137429A0 (en) Methods and compsitions for treating diseases and conditions of the eye
HUP0302718A3 (en) Methods and compositions for the treatment of diseases of the eye
AU2001256855A1 (en) Preparation for the prevention and treatment of ocular disorders
AU2001259085A1 (en) Treatment of ocular neovascularization and related diseases
NL1010351A1 (en) Esters of carotenoids for use in the prevention and treatment of eye diseases.
AU1794801A (en) Method for treatment and prevention of physiological shock
AU2307899A (en) Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
HK1048439A1 (en) Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage
AU3737500A (en) Method of preventing the death of retinal neurons and treating ocular diseases
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
DE69739190D1 (en) MEDICAMENT FOR THE TREATMENT OF OCULAR CRUSH DISEASES

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase